These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 6190882

  • 1. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic.
    Zimakoff J, Høiby N, Rosendal K, Guilbert JP.
    J Hosp Infect; 1983 Mar; 4(1):31-40. PubMed ID: 6190882
    [Abstract] [Full Text] [Related]

  • 2. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in the Danish Cystic Fibrosis Centre.
    Zembrzuska-Sadkowska E, Sneum M, Ojeniyi B, Heiden L, Høiby N.
    J Hosp Infect; 1995 Jan; 29(1):1-7. PubMed ID: 7738336
    [Abstract] [Full Text] [Related]

  • 3. The social network of cystic fibrosis centre care and shared Pseudomonas aeruginosa strain infection: a cross-sectional analysis.
    Kidd TJ, Soares Magalhães RJ, Paynter S, Bell SC, ACPinCF Investigator Group.
    Lancet Respir Med; 2015 Aug; 3(8):640-50. PubMed ID: 26208994
    [Abstract] [Full Text] [Related]

  • 4. Hospital epidemiology of Pseudomonas aeruginosa from patients with cystic fibrosis.
    Speert DP, Campbell ME.
    J Hosp Infect; 1987 Jan; 9(1):11-21. PubMed ID: 2880893
    [Abstract] [Full Text] [Related]

  • 5. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces.
    Panagea S, Winstanley C, Walshaw MJ, Ledson MJ, Hart CA.
    J Hosp Infect; 2005 Feb; 59(2):102-7. PubMed ID: 15620443
    [Abstract] [Full Text] [Related]

  • 6. Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center.
    Jones AM, Dodd ME, Govan JR, Doherty CJ, Smith CM, Isalska BJ, Webb AK.
    Am J Respir Crit Care Med; 2005 Feb 01; 171(3):257-60. PubMed ID: 15542795
    [Abstract] [Full Text] [Related]

  • 7. Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic.
    Cheng K, Smyth RL, Govan JR, Doherty C, Winstanley C, Denning N, Heaf DP, van Saene H, Hart CA.
    Lancet; 1996 Sep 07; 348(9028):639-42. PubMed ID: 8782753
    [Abstract] [Full Text] [Related]

  • 8. Comparative hygienic surveillance of contamination with pseudomonads in a cystic fibrosis ward over a 4-year period.
    Bosshammer J, Fiedler B, Gudowius P, von der Hardt H, Römling U, Tümmler B.
    J Hosp Infect; 1995 Dec 07; 31(4):261-74. PubMed ID: 8926376
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. How and why to monitor Pseudomonas aeruginosa infections in the long term at a cystic fibrosis centre.
    Kalferstova L, Vilimovska Dedeckova K, Antuskova M, Melter O, Drevinek P.
    J Hosp Infect; 2016 Jan 07; 92(1):54-60. PubMed ID: 26597636
    [Abstract] [Full Text] [Related]

  • 11. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward.
    Döring G, Jansen S, Noll H, Grupp H, Frank F, Botzenhart K, Magdorf K, Wahn U.
    Pediatr Pulmonol; 1996 Feb 07; 21(2):90-100. PubMed ID: 8882212
    [Abstract] [Full Text] [Related]

  • 12. Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients.
    Tümmler B, Koopmann U, Grothues D, Weissbrodt H, Steinkamp G, von der Hardt H.
    J Clin Microbiol; 1991 Jun 07; 29(6):1265-7. PubMed ID: 1907611
    [Abstract] [Full Text] [Related]

  • 13. A 1-m distance is not safe for children with cystic fibrosis at risk for cross-infection with Pseudomonas aeruginosa.
    Festini F, Taccetti G, Galici V, Neri S, Bisogni S, Ciofi D, Braggion C.
    Am J Infect Control; 2010 Apr 07; 38(3):244-5. PubMed ID: 20129701
    [Abstract] [Full Text] [Related]

  • 14. Molecular epidemiology of Pseudomonas aeruginosa infections in a cystic fibrosis outpatient clinic.
    DA Silva Filho LVF, Levi JE, Bento CNO, Rodrigues JC, DA Silva Ramos SRT.
    J Med Microbiol; 2001 Mar 07; 50(3):261-267. PubMed ID: 11232773
    [Abstract] [Full Text] [Related]

  • 15. Cross-infections with Pseudomonas aeruginosa in patients with cystic fibrosis attending the Warsaw Centre.
    Milczewska J, Wołkowicz T, Zacharczuk K, Kwiatkowska M.
    Dev Period Med; 2015 Mar 07; 19(1):60-5. PubMed ID: 26003071
    [Abstract] [Full Text] [Related]

  • 16. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic.
    Jones AM, Govan JR, Doherty CJ, Dodd ME, Isalska BJ, Stanbridge TN, Webb AK.
    Lancet; 2001 Aug 18; 358(9281):557-8. PubMed ID: 11520529
    [Abstract] [Full Text] [Related]

  • 17. Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection?
    Pedersen SS, Jensen T, Pressler T, Høiby N, Rosendal K.
    Acta Paediatr Scand; 1986 Sep 18; 75(5):840-5. PubMed ID: 3105236
    [Abstract] [Full Text] [Related]

  • 18. Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics.
    Armstrong D, Bell S, Robinson M, Bye P, Rose B, Harbour C, Lee C, Service H, Nissen M, Syrmis M, Wainwright C.
    J Clin Microbiol; 2003 May 18; 41(5):2266-7. PubMed ID: 12734299
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
    Campana S, Taccetti G, Ravenni N, Masi I, Audino S, Sisi B, Repetto T, Döring G, de Martino M.
    J Cyst Fibros; 2004 Aug 18; 3(3):159-63. PubMed ID: 15463902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.